A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
UAB Comprehensive Cancer Center holds annual ArtBLINK Gala to support high-priority research and patient and family assistance.
Cycliad, a unique biking event, comes to Birmingham for the first time to support navigation services for cancer patients.
Proceeds from the Fiesta Ball are used to fund a competitive grant award for a young cancer researcher at UAB to jumpstart his or her research.
New marker predicts how resistant each patient’s brain cancer will be to chemotherapy.
The Supportive Care and Survivorship Clinical Program is competing in an online vote on that ends at 5 p.m. on March 28.
The newly-renovated facility opened to improve patient health, comfort and convenience by making treatments available in one building.